<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Regulatory actions</title>
    <description></description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Regulatory actions for July 2, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Galderma, Intent, Kowa, Nicox, Orca, Penumbra, Scibase, Serenity, Siemens, Skylinedx.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Galderma, Intent, Kowa, Nicox, Orca, Penumbra, Scibase, Serenity, Siemens, Skylinedx.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732283</guid>
      <pubDate>Thu, 02 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732283-regulatory-actions-for-july-2-2026</link>
    </item>
    <item>
      <title>Regulatory actions for July 1, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Aurenar, Biomerieux, Cogent, Envoy, Hengrui, Monopar, Novaliq, Novocure, Praxis, Roche, Saluda, Sarepta, Starmed, Unicycive.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arcutis, Aurenar, Biomerieux, Cogent, Envoy, Hengrui, Monopar, Novaliq, Novocure, Praxis, Roche, Saluda, Sarepta, Starmed, Unicycive.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732267</guid>
      <pubDate>Wed, 01 Jul 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732267-regulatory-actions-for-july-1-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 30, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Bavarian, Biodexa, Cansino, Capricor, Daiichi, Eisai, Lantheus, Larimar, Nuvation, Satellos, Senzime, SOBI, United, Viridian, Zambon.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Bavarian, Biodexa, Cansino, Capricor, Daiichi, Eisai, Lantheus, Larimar, Nuvation, Satellos, Senzime, SOBI, United, Viridian, Zambon.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732253</guid>
      <pubDate>Tue, 30 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732253-regulatory-actions-for-june-30-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 30, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Biokin, Carsgen, China Medical System, Daiichi Sankyo, Everest Medicines, Incyte Biosciences Japan, Merz, Natera, Novo Nordisk, Reprocell, Sanofi, Sumitomo, Systimmune, Teijin, Valgen Medtech.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Biokin, Carsgen, China Medical System, Daiichi Sankyo, Everest Medicines, Incyte Biosciences Japan, Merz, Natera, Novo Nordisk, Reprocell, Sanofi, Sumitomo, Systimmune, Teijin, Valgen Medtech.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732307</guid>
      <pubDate>Tue, 30 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732307-regulatory-actions-for-june-30-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 29, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Arbor, Astrazeneca, Daiichi, Eli Lilly, Everest, Incyte, Johnson, Maat, Omeros, Pharmaessentia, Replimune, Xspray.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Acadia, Amgen, Arbor, Astrazeneca, Daiichi, Eli Lilly, Everest, Incyte, Johnson, Maat, Omeros, Pharmaessentia, Replimune, Xspray.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732239</guid>
      <pubDate>Mon, 29 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732239-regulatory-actions-for-june-29-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 26, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aidoc, Celecor, Cercare, Deephealth, Gilead, Ionis, Merck, Pfizer, Radnet, Reprocell, Spectral, Sunshine.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Aidoc, Celecor, Cercare, Deephealth, Gilead, Ionis, Merck, Pfizer, Radnet, Reprocell, Spectral, Sunshine.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732182</guid>
      <pubDate>Fri, 26 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732182-regulatory-actions-for-june-26-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 25, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Brightheart, Hepquant, Life, Merck, Natera, Valgen.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Brightheart, Hepquant, Life, Merck, Natera, Valgen.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732168</guid>
      <pubDate>Thu, 25 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732168-regulatory-actions-for-june-25-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 24, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Arrowhead, Biokin, Calico, China Medical System, Diasorin, Draeger, ECM, Gilead, Lem, Orion, Portal, Quoin, Sanofi, Spotlight, Systimmune, US Worldmeds.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Arrowhead, Biokin, Calico, China Medical System, Diasorin, Draeger, ECM, Gilead, Lem, Orion, Portal, Quoin, Sanofi, Spotlight, Systimmune, US Worldmeds.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732086</guid>
      <pubDate>Wed, 24 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732086-regulatory-actions-for-june-24-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 23, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Achieve, Carsgen, Exeltis USA, Incyte, Masimo, Merz, Moderna, Novo Nordisk, Praxis, Regeneron, Sanofi, Sumitomo, Teijin, Tetmedical, Teva, Viiv.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Achieve, Carsgen, Exeltis USA, Incyte, Masimo, Merz, Moderna, Novo Nordisk, Praxis, Regeneron, Sanofi, Sumitomo, Teijin, Tetmedical, Teva, Viiv.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732072</guid>
      <pubDate>Tue, 23 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732072-regulatory-actions-for-june-23-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 23, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Iaso, Qihan, Zai Lab.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Iaso, Qihan, Zai Lab.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732150</guid>
      <pubDate>Tue, 23 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732150-regulatory-actions-for-june-23-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 22, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Corcept, E-Scopics, GRI, GSK, Iaso, Merck, Roche, Spero.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Corcept, E-Scopics, GRI, GSK, Iaso, Merck, Roche, Spero.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/732058</guid>
      <pubDate>Mon, 22 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/732058-regulatory-actions-for-june-22-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 18, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Fibersense, Sernova, Uniqure, Vygon, Xaga.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Fibersense, Sernova, Uniqure, Vygon, Xaga.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731929</guid>
      <pubDate>Thu, 18 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731929-regulatory-actions-for-june-18-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 17, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Gilead, Inhibrx, Novabridge, Outlook, Qihan, SK, Surgentec, Zai Lab.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Gilead, Inhibrx, Novabridge, Outlook, Qihan, SK, Surgentec, Zai Lab.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731915</guid>
      <pubDate>Wed, 17 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731915-regulatory-actions-for-june-17-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 16, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alk, Astrazeneca, Bayer, Belite, Guardant, Merck, Precigen, Roche, Sanofi.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alk, Astrazeneca, Bayer, Belite, Guardant, Merck, Precigen, Roche, Sanofi.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731901</guid>
      <pubDate>Tue, 16 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731901-regulatory-actions-for-june-16-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 16, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Oncolys, Pharmaessentia, Remegen, Takeda, Vcare, Vor, Zai Lab.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Oncolys, Pharmaessentia, Remegen, Takeda, Vcare, Vor, Zai Lab.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731956</guid>
      <pubDate>Tue, 16 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731956-regulatory-actions-for-june-16-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 15, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Alkermes, GSK, Novo Nordisk, Penumbra.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Akeso, Alkermes, GSK, Novo Nordisk, Penumbra.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731885</guid>
      <pubDate>Mon, 15 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731885-regulatory-actions-for-june-15-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 12, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Camurus, Guardant, Karl Storz, Pharmaessentia, Roche, Wave.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Camurus, Guardant, Karl Storz, Pharmaessentia, Roche, Wave.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731825</guid>
      <pubDate>Fri, 12 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731825-regulatory-actions-for-june-12-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 11, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cellectis, Dermasensor, Eli Lilly, Italfarmaco, Onkos, Organon, Radiomedix, Sibel, Subtle, Takeda, Tris, Vara.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cellectis, Dermasensor, Eli Lilly, Italfarmaco, Onkos, Organon, Radiomedix, Sibel, Subtle, Takeda, Tris, Vara.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731811</guid>
      <pubDate>Thu, 11 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731811-regulatory-actions-for-june-11-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 10, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atavistik, Chiesi, Disc, Gen1e, Matisse, Personalis, Redhill, Vertanical, Xenix, Zai Lab.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Atavistik, Chiesi, Disc, Gen1e, Matisse, Personalis, Redhill, Vertanical, Xenix, Zai Lab.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731731</guid>
      <pubDate>Wed, 10 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731731-regulatory-actions-for-june-10-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 9, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Artiva, Intrabio, Oncolys, Pfizer, Sanofi, Vcare, Vor, Remegen, Xspray.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Artiva, Intrabio, Oncolys, Pfizer, Sanofi, Vcare, Vor, Remegen, Xspray.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731717</guid>
      <pubDate>Tue, 09 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731717-regulatory-actions-for-june-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 9, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Haisco, Innovent, Iovance, Lupeng, Lupin, Nxera, Quoin, Reach Surgical, Santhera, Shionogi, Wockhardt.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Haisco, Innovent, Iovance, Lupeng, Lupin, Nxera, Quoin, Reach Surgical, Santhera, Shionogi, Wockhardt.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731797</guid>
      <pubDate>Tue, 09 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731797-regulatory-actions-for-june-9-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 8, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Chiesi, Lupin, Tandem.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Chiesi, Lupin, Tandem.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731703</guid>
      <pubDate>Mon, 08 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731703-regulatory-actions-for-june-8-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 5, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Amneal, Attralus, Biogen, GE, Innovent, Iovance, Kashiv, Lupeng, Mammotome, Pharming, Quoin, Verastem, Xbrane, Zepto.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alvotech, Amneal, Attralus, Biogen, GE, Innovent, Iovance, Kashiv, Lupeng, Mammotome, Pharming, Quoin, Verastem, Xbrane, Zepto.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731642</guid>
      <pubDate>Fri, 05 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731642-regulatory-actions-for-june-5-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 4, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Agilent, Coloplast, Cycle, Hopstem, Orthalign, QT, Reach, Royal, Sotio, Terremoto, Waters, Xenix.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731628</guid>
      <pubDate>Thu, 04 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731628-regulatory-actions-for-june-4-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 3, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Amgen, Foundation, Intelligent, Johnson, Merakris, Nxera, Pasithea, Roche, Santhera.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Amgen, Foundation, Intelligent, Johnson, Merakris, Nxera, Pasithea, Roche, Santhera.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731551</guid>
      <pubDate>Wed, 03 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731551-regulatory-actions-for-june-3-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 2, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: BMS, Cercare, Foundation, Haisco, Kamada, Mannkind, Nouscom, Outlook, Polypid, Shionogi, Surgentec, Vertex, Wockhardt.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: BMS, Cercare, Foundation, Haisco, Kamada, Mannkind, Nouscom, Outlook, Polypid, Shionogi, Surgentec, Vertex, Wockhardt.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731537</guid>
      <pubDate>Tue, 02 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731537-regulatory-actions-for-june-2-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 2, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Boehringer Ingelheim, Cornerstone Robotics, Daiichi Sankyo, Dizal, Gene Solutions, H. Lundbeck, Innocare, Optimi Health, Skia, Vanda, Zydus.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Boehringer Ingelheim, Cornerstone Robotics, Daiichi Sankyo, Dizal, Gene Solutions, H. Lundbeck, Innocare, Optimi Health, Skia, Vanda, Zydus.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731615</guid>
      <pubDate>Tue, 02 Jun 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731615-regulatory-actions-for-june-2-2026</link>
    </item>
    <item>
      <title>Regulatory actions for June 1, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Coredio, Johnson, Merck, Neuropace, Optimi, Replimune, Skia, Spectral, Tempus, Zydus.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Astrazeneca, Coredio, Johnson, Merck, Neuropace, Optimi, Replimune, Skia, Spectral, Tempus, Zydus.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731523</guid>
      <pubDate>Mon, 01 Jun 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731523-regulatory-actions-for-june-1-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 29, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Beren, Cogent, Corcept, Enterome, Gene Solutions, Innocare, Ironwood, Renovorx, Sanofi, Solu, Zenas.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Abbvie, Beren, Cogent, Corcept, Enterome, Gene Solutions, Innocare, Ironwood, Renovorx, Sanofi, Solu, Zenas.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731465</guid>
      <pubDate>Fri, 29 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731465-regulatory-actions-for-may-29-2026</link>
    </item>
    <item>
      <title>Regulatory actions for May 28, 2026</title>
      <description>Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Bridgebio, Cardiosense, Corcept, Dizal, Innocare, Nuvalent, Precigen, Senzime, Subtle, Vanda.</description>
      <content:encoded>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Astrazeneca, Atmo, Bridgebio, Cardiosense, Corcept, Dizal, Innocare, Nuvalent, Precigen, Senzime, Subtle, Vanda.]]>
      </content:encoded>
      <guid>http://www.bioworld.com/articles/731451</guid>
      <pubDate>Thu, 28 May 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/731451-regulatory-actions-for-may-28-2026</link>
    </item>
  </channel>
</rss>
